Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1

This publication has 20 references indexed in Scilit:

• Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
  Gastroenterology, 2007
• The α4bβ7‐integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine
  Clinical & Experimental Allergy, 2006
• Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists
  Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2004
• Integrins
  Cell, 2002
• Effects of VLA‐4 antagonists in rat whole embryo culture
  Teratology, 2002
• α₄ integrin‐dependent eosinophil recruitment in allergic but not non‐allergic inflammation
  British Journal of Pharmacology, 2001
• Integrin Activation by Dithiothreitol or Mn2+ Induces a Ligand-occupied Conformation and Exposure of a Novel NH2-terminal Regulatory Site on the β1Integrin Chain
  Journal of Biological Chemistry, 1998
• Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.
  Journal of Clinical Investigation, 1997
• A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment
  British Journal of Pharmacology, 1997
• Integrin α₄β₇ mediates human eosinophil interaction with MAdCAM‐1, VCAM‐1 and fibronectin
  Immunology, 1996